Morgan Wade is undergoing a major surgery in November.
She revealed to Page Six that she will be having a preventative double mastectomy in November, after testing positive for the BRCA gene.
She learned of the gene during a gig in Europe last year, adding that her mom has already been through it and her younger cousin is planning to have the surgery, as well.
Morgan will continue touring until November, and then take those two months off to rest. She says the worst part about it is that she won’t be able to work out for a little while, which is something she’s used to doing every single day:
“I had the BRCA gene, it’s a breast cancer gene so I’m having a double mastectomy in November.
I’m going really hard up until November so then November and December I have off to rest. I’m feeling fine, I’m just pissed I won’t be able to work out because I really like working out. That’s my only qualm about it.
My mom had it, and my little cousin is going to get it, but I’ll be fine.”
The BCRA1 and BCRA2 genes produce proteins that repair damaged DNA, according to the National Cancer Institute, and when someone inherits harmful variants of one of them, they have an increased risk of several types of cancers, including breast cancer.
It isn’t uncommon for women who have this gene to have the double mastectomy in order to majorly decrease their risk of getting breast cancer.
Morgan is also gearing up to release her sophomore studio album Psychopath on August 25th, and she just released the title track last Friday.
She says the album will focus on everything she’s been through since her debut Reckless came out in 2021:
“With ‘Psychopath,’ we’ve done a really good job of moving on from ‘Reckless,’ to the next stage without it being so crazy different.
I’m excited, every song on there has its own sound and is completely different. The album goes into where I’m at in life right now.
Which is so busy. It’s about growing up and being older, and starting to feel like, ‘Is it time to settle down?’ I think you’ll see a lot of that on the record.”
Morgan announced the news herself in a post on Instagram, saying that she plans to open up more about all of this in the future, in addition to thanking her fans for their continued support:
“I’ll go in depth later, but I was diagnosed with the #rad51d gene a while back. In November I’ll undergo a double mastectomy as a preventative.
As always appreciate you all (I was nervous and said BRCA in the interview – that’s why I always need my mom with me).”
Morgan also shared some information on the mutation, as well as resources for other women to learn more about it:
“Info on Rad51d: Women with a #RAD51D mutation have about a 10-20 percent lifetime risk for ovarian, fallopian tube or primary peritoneal cancer (these three cancers and their risks are related and are often referred to together as ovarian cancer).
Women with a #RAD51D mutation have about a 20-40 percent lifetime risk for breast cancer with a tendency for triple-negative breast cancer. (https://www.facingourrisk.org).”
Our best wishes to Morgan for her surgery in November, and I’m sure she’ll be back and better than ever in no time after she has some time to recover later this year.